Clinical Trials Directory

Trials / Completed

CompletedNCT05637814

Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
0 Minutes – 21 Days
Healthy volunteers
Accepted

Summary

The purpose of this study is to implement and externally validate an inpatient ML algorithm that combines pulse oximetry features for critical congenital heart disease (CCHD) screening.

Detailed description

The study will externally validate an algorithm that combines non-invasive oxygenation and perfusion measurements as a screening tool for CCHD. In a previous study, the investigators created an algorithm that combines non-invasive measurements of oxygenation and perfusion over at least two measurements using machine learning (ML) techniques. The prior model was created and tested using internal validation (k-fold validation). Thus, the investigators will test the model on an external sample of patients to test generalizability of the model. Additionally, the team will trial a repeated measurement for any "failure" of the screen to assess impact on the false positive rate. Study team will also use repeated pulse oximetry measurements (up to 4 total and including measurements after 48 hours of age, which may be done outpatient) to create a new algorithm that incorporates new data over time. The central hypothesis is that the addition of non-invasive perfusion measurements will be superior to SpO2-alone screening for CCHD detection and a model that incorporates repeated measurements will enhance detection of CCHD while preserving the specificity.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSpO2/PIx Measurement and ML AlgorithmRight upper and any lower extremity oxygen saturation (SpO2) and perfusion index (PIx) will be measured and an online ML inference model will be used to classify a newborn as healthy versus CCHD as new pulse oximetry data is collected.

Timeline

Start date
2023-08-17
Primary completion
2024-08-02
Completion
2024-08-02
First posted
2022-12-05
Last updated
2025-07-16

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05637814. Inclusion in this directory is not an endorsement.